trial

Validation of a Clinical Screening Grid for Syndromic Schizophrenia

NCTId NCT02746510
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 129 (actual)
Sponsored by Hôpital le Vinatier
Primary completion 2023-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
129 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2016-07
Primary completion
2023-02
Eligibility
ALL · 15 Years

Interventions & indications

Drugs
Array comparative genomic hybridization

Sponsors

Hôpital le VinatierLead Sponsor
Hospices Civils de LyonCollaborator

Investigators

1
POISSON Alice, PHPrincipal Investigator

Sites

1 total
Bron, France

Facts & assertions

4 sourced
Enrollment
129
Phase
NA
Primary Completion Date
2023-02
Status
TERMINATED
relationships
The graph out of here
drug
Array comparative genomic hybridization
drug
lead_sponsor
Hôpital le Vinatier
company
collaborator
Hospices Civils de Lyon
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
POISSON Alice, PH
person